(Total Views: 138)
Posted On: 01/29/2024 8:15:50 AM
Post# of 21237

$VSTM News Article - Verastem Oncology Outlines Key 2024 Strategic Priorities and Upcoming Catalysts for Advancing Avutometinib and Defactinib and Broader Pipeline in RAS Pathway-Driven Cancers https://marketwirenews.com/news-releases/vera...25407.html


My Twitter: WhyteStocks